{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:15:48Z","timestamp":1792880148965,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.neuropharm.2010.05.004","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T08:48:18Z","timestamp":1274518098000},"page":"367-374","source":"Crossref","is-referenced-by-count":436,"title":["Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues"],"prefix":"10.1016","volume":"59","author":[{"given":"Viktor","family":"Lakics","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Karran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Boess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.05.004_bib1","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.ajhg.2008.04.019","article-title":"Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function","volume":"82","author":"Arnaud-Lopez","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cellsig.2003.08.009","article-title":"Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression","volume":"16","author":"Bender","year":"2004","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2004.07.040","article-title":"Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance","volume":"47","author":"Boess","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.tibs.2006.10.002","article-title":"Epac proteins: multi-purpose cAMP targets","volume":"31","author":"Bos","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0026-0495(03)00271-3","article-title":"Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion","volume":"52","author":"Cheung","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib7","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI24867","article-title":"Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice","volume":"116","author":"Choi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0898-6568(01)00207-8","article-title":"Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants","volume":"14","author":"Fidock","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib9","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408369991239213","article-title":"Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action","volume":"36","author":"Francis","year":"1999","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib11","doi-asserted-by":"crossref","first-page":"18438","DOI":"10.1074\/jbc.274.26.18438","article-title":"Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)","volume":"274","author":"Fujishige","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.tem.2006.06.006","article-title":"Membrane guanylyl cyclase receptors: an update","volume":"17","author":"Garbers","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s004390050838","article-title":"Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence","volume":"103","author":"Guipponi","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pharmtox.41.1.145","article-title":"Regulation and role of adenylyl cyclase isoforms","volume":"41","author":"Hanoune","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/nar\/30.1.214","article-title":"HugeIndex: a database with visualization tools for high-density oligonucleotide array data from normal human tissues","volume":"30","author":"Haverty","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.1998.9379","article-title":"Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3\u2032,5\u2032-cyclic nucleotide phosphodiesterase","volume":"250","author":"Hayashi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1152\/physrev.00008.2002","article-title":"Cyclic nucleotide-gated ion channels","volume":"82","author":"Kaupp","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/bbrc.1999.1013","article-title":"Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP","volume":"61","author":"Kotera","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib18","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.283.5403.848","article-title":"CD3- and CD28-dependent induction of PDE7 required for T cell activation","volume":"283","author":"Li","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1074\/jbc.271.2.796","article-title":"Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3\u2032,5\u2032-cyclic nucleotide phosphodiesterases","volume":"271","author":"Loughney","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1119(99)00171-7","article-title":"Isolation and characterization of PDE10A, a novel human 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase","volume":"234","author":"Loughney","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0021-9258(18)52413-3","article-title":"High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells","volume":"266","author":"MacFarland","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib22","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.1093\/nar\/gkh435","article-title":"BLAST: at the core of a powerful and diverse set of sequence analysis tools","volume":"32","author":"McGinnis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2741\/1617","article-title":"NO-sensitive guanylyl cyclase and NO-induced feedback inhibition in cGMP signaling","volume":"10","author":"Mullershausen","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0891-0618(00)00097-1","article-title":"Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography. Comparison with monkey and rat brain","volume":"20","author":"P\u00e9rez-Torres","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0014-4886(03)00042-6","article-title":"Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer\u2019s disease brains examined by in situ hybridization","volume":"182","author":"P\u00e9rez-Torres","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib26","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1523\/JNEUROSCI.22-12-05188.2002","article-title":"Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning","volume":"22","author":"Reed","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0306-4522(95)00520-X","article-title":"Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain","volume":"72","author":"Reinhardt","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0006-291X(03)00021-4","article-title":"Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene","volume":"301","author":"Rentero","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.neuroscience.2005.01.050","article-title":"Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain","volume":"132","author":"Reyes-Irisarri","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib30","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1111\/j.1460-9568.2007.05589.x","article-title":"Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer\u2019s disease human brains","volume":"25","author":"Reyes-Irisarri","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2008.06349.x","article-title":"Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice","volume":"28","author":"Rutten","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/002215549904700707","article-title":"Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothelial cells","volume":"47","author":"Sadhu","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia","volume":"325","author":"Schmidt","year":"2008","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(03)02754-9","article-title":"Immunohistochemical localization of PDE10A in the rat brain","volume":"985","author":"Seeger","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00213-007-1014-6","article-title":"Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme","volume":"197","author":"Siuciak","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuropharm.2006.04.013","article-title":"Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis","volume":"51","author":"Siuciak","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1369\/jhc.2009.953471","article-title":"Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species","volume":"57","author":"Stephenson","year":"2009","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib35","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.cellsig.2007.03.012","article-title":"Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice","volume":"19","author":"Sun","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib37","doi-asserted-by":"crossref","first-page":"32749","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic Nucleotide Phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2010.05.004_bib39","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.npp.1301537","article-title":"Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)","volume":"33","author":"Zhang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.05.004_bib40","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T03:15:14Z","timestamp":1635390914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0028390810001292"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.05.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}